Growth factorsPub Date : 2026-07-19DOI: 10.1080/08977194.2026.2704554
Mantas Dirmontas, Petras Minderis, Aivaras Ratkevicius
{"title":"Effects of aging in combination with high-fat or ketogenic diet on skeletal muscle hypertrophy after functional overloading in C57BL/6J mice.","authors":"Mantas Dirmontas, Petras Minderis, Aivaras Ratkevicius","doi":"10.1080/08977194.2026.2704554","DOIUrl":"https://doi.org/10.1080/08977194.2026.2704554","url":null,"abstract":"<p><p>We investigated how aging interacts with high-fat (HFD) and ketogenic (KD) diets to influence functional overload (FO)-induced muscle hypertrophy in C57BL/6J mice. Male mice aged 3, 16, and 24 months were fed regular chow (RD), HFD, or KD for 12 weeks, with FO of the plantaris muscle induced by denervation of the soleus and gastrocnemius during the final 6 weeks (n = 8-10 per group). Muscle hypertrophy was unaffected by diet (p = 0.897) but declined with age (p < 0.001), with a marked reduction already in mature mice. Plasma IGF-1 was higher in adult than mature (p < 0.05) and old (p < 0.001) mice and correlated positively with hypertrophy (r = 0.29, p = 0.01). The weak correlation of hypertrophy with plasma IGF-I levels suggests that IGF-I is only one among many factors playing a role in muscle hypertrophy.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"1-13"},"PeriodicalIF":1.9,"publicationDate":"2026-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-05-01Epub Date: 2026-04-08DOI: 10.1080/08977194.2026.2656185
Fadhil Ahsan, Nanda Yuli Rahmawati, Fidyah Nanda Alditia, Alfin Firasy Mufid, Ashon Sa'adi, Sri Ratna Dwiningsih, M Y Ardianta Widyanugraha, Arif Tunjungseto, Budi Santoso
{"title":"Role of soluble EGFR, Fas, and Fas ligand in pelvic pain severity and their association with endometriosis in infertile woman: a case-control study.","authors":"Fadhil Ahsan, Nanda Yuli Rahmawati, Fidyah Nanda Alditia, Alfin Firasy Mufid, Ashon Sa'adi, Sri Ratna Dwiningsih, M Y Ardianta Widyanugraha, Arif Tunjungseto, Budi Santoso","doi":"10.1080/08977194.2026.2656185","DOIUrl":"10.1080/08977194.2026.2656185","url":null,"abstract":"<p><p>Endometriosis, a chronic inflammatory condition linked to pelvic pain and infertility, is characterized by immune dysfunction involving dysregulated apoptosis and cell proliferation. This case-control study included 87 infertile women undergoing diagnostic laparoscopy and assessed serum and peritoneal levels of sEGFR, sFas, and sFasL using ELISA. Pain intensity was evaluated via the Visual Analog Scale (VAS). Peritoneal sFasL concentrations were significantly higher in infertile women with pelvic pain (<i>p</i> = 0.012) and correlated with VAS scores (<i>r</i> = 0.261, <i>p</i> = 0.014). Serum and peritoneal sFasL levels were significantly elevated in endometriosis patients with pelvic pain compared to controls (<i>p</i> = 0.003, <i>p</i> = 0.002, respectively). Peritoneal sFasL levels were also associated with dysmenorrhea and dyspareunia. ROC analysis demonstrated that serum sFasL differentiated endometriosis from controls (AUC = 0.797, <i>p</i> < 0.001). These findings suggest that sFasL may serve as a potential noninvasive biomarker for endometriosis. Further research should investigate its regulatory role in endometriosis-related pain.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"125-137"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147638532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BMP7 peripheral sequence evolution correlates with mammalian cloacal septation.","authors":"Aditi Kaloni, Meghal Vaishnani, Mansi Popat, Swayamprabha Samantaray, Shrinal Vasa, Anupama Modi, Bhavin Parekh","doi":"10.1080/08977194.2026.2696513","DOIUrl":"10.1080/08977194.2026.2696513","url":null,"abstract":"<p><p>Vertebrate evolution from a single multipurpose cloaca to separate urogenital and anal openings remains a central molecular question with relevance to reproductive diversification and anorectal malformations. We investigated BMP7, a critical regulator of cloacal formation, across 37 vertebrates from cartilaginous fish to mammals using phylogenetics, sequence alignment, physicochemical assessment, domain analysis, motif analysis and molecular docking. The BMP7 core TGF-beta domain was highly conserved (>90% identity), whereas peripheral regions showed significant habitat-associated divergence (<i>p</i> < 0.01), including shifts in isoelectric point between aquatic and terrestrial vertebrates (pI 6.22-6.97 to 6.98-8.98) and altered stability indices. A key finding was that placental mammals, in which cloacal septation produces distinct anorectal and urogenital outlets, showed lineage-specific amino-acid changes, including Pro111Ala, linked to predicted BMP7-FOXA1 regulatory refinement. MEME analysis identified mammal-bird GWQDWI conservation and amphibian-reptile RACGCH divergence, supporting peripheral BMP7 adaptation during cloacal evolution.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"138-149"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148420644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-05-01Epub Date: 2026-03-31DOI: 10.1080/08977194.2026.2649730
Chin Wee Tan, Ruiyan Zhu, Serena R Kane, Michelle Au, Xiaoyu Zhang, Yumiko Hirokawa, Maree C Faux, Antony W Burgess
{"title":"ErbB receptor stimulation is required for mouse Colon adenoma organoids to form crypts.","authors":"Chin Wee Tan, Ruiyan Zhu, Serena R Kane, Michelle Au, Xiaoyu Zhang, Yumiko Hirokawa, Maree C Faux, Antony W Burgess","doi":"10.1080/08977194.2026.2649730","DOIUrl":"10.1080/08977194.2026.2649730","url":null,"abstract":"<p><p>When cultured with Wnt, R-spondin, EGF, Noggin, myofibroblast conditioned medium and Matrigel, crypts from normal mouse colon mucosa form crypt-producing organoids and can be passaged every seven days. Under the same culture and passage conditions, crypts isolated from colon adenomas derived from Apc<sup>min/+</sup> mice typically grow as spheroidal cysts and do not produce crypts. The adenoma organoids require EGF, but not Wnt, R-spondin or Noggin for continuous passaging. However, when mouse colon adenoma spheroids are grown for more than 10 days in the presence of EGF, crypt formation occurs. EGF, EREG, β-cellulin, Neuregulin-1 or AREG are sufficient for initiating crypt formation, however, neuregulin-1 is more potent than the other EGF-family members. EGFR and ErbB2 inhibitors both prevent crypt formation in these adenoma cultures. Either EGFR:ErbB2 or ErbB3:ErbB2 signaling is sufficient to initiate adenoma crypt budding and elongation. ErbB2 inhibitors may provide a therapeutic avenue for ablating colon adenomas.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"106-124"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147591787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-05-01Epub Date: 2026-05-28DOI: 10.1080/08977194.2026.2671736
Jingwei Ye, Yuan Wen, Jingyang Zhan, Khaing Wut Yi Hla, Tong Li, Zhiyu Xiao, Xianghan Shu
{"title":"The role of ERK signaling pathway in pituitary adenomas: from molecular mechanisms to targeted therapy.","authors":"Jingwei Ye, Yuan Wen, Jingyang Zhan, Khaing Wut Yi Hla, Tong Li, Zhiyu Xiao, Xianghan Shu","doi":"10.1080/08977194.2026.2671736","DOIUrl":"10.1080/08977194.2026.2671736","url":null,"abstract":"<p><p>ERK, a core member of the MAPK family, operates through the classical Ras/Raf/MEK/ERK signaling cascade. Abnormal activation of this pathway is closely associated with malignant tumor progression and represents a critical target in anticancer drug development. In this article, we systematically describe the regulatory network of the ERK pathway, including negative feedback mechanisms, cross-pathway interactions, non-coding RNAs, and epigenetic regulation, with a particular focus on ERK's dual role-promoting both cell proliferation and apoptosis-in pituitary adenomas compared to other tumors. Additionally, we explore emerging ERK-targeted therapies and their associated resistance mechanisms. Despite substantial research on ERK, further investigation into its underlying mechanisms is warranted. We propose the construction of computational modeling approaches to analyze these complex regulatory relationships and to develop precise combination therapies aimed at overcoming resistance. Such strategies could enable personalized treatment and offer more effective solutions for managing pituitary tumors and other malignancies.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"77-93"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148042039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-05-01Epub Date: 2026-07-02DOI: 10.1080/08977194.2026.2695623
Daria Piskareva, Yana Zorkina, Alisa Andryushenko, Georgy Kostyuk
{"title":"The role of the epidermal growth factor in the pathogenesis of schizophrenia. Clinical and diagnostic value.","authors":"Daria Piskareva, Yana Zorkina, Alisa Andryushenko, Georgy Kostyuk","doi":"10.1080/08977194.2026.2695623","DOIUrl":"10.1080/08977194.2026.2695623","url":null,"abstract":"<p><p>Research increasingly implicates neuroimmune inflammation in schizophrenia, with the epidermal growth factor (EGF) family as a potential link. This review critically evaluates EGF family members as diagnostic, risk, and treatment response markers.The most consistent finding is decreased serum EGF in chronic schizophrenia, confirmed in postmortem brain and independent of antipsychotics. First-episode data are heterogeneous, reflecting differences in medication status, population, and illness stage.Genetic studies of EGF rs4444903 show no consistent disease risk association but demonstrate a replicable, sex-specific effect on age at onset in males. Stronger evidence implicates NRG1 type IV and NRG3 polymorphisms in disease biology.Serum EGF is not a reliable treatment response marker. In summary, EGF alone is not clinically useful. Its value lies in consistent reduction in chronic patients, sex-specific effects on age at onset, and robust links of NRG1 and NRG3 to schizophrenia.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"94-105"},"PeriodicalIF":1.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148375506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-02-01Epub Date: 2025-12-26DOI: 10.1080/08977194.2025.2606677
Farheen Showket, Aubaidah Akhtar, Sabra Parveen, Neetu Badesra, Mir Owais Ayaz, Md Mehedi Hossain, Mohmmad Saleem Dar, Razak Hussain, Pankaj Keshari, Riyaz A Mir, Mohd Jamal Dar
{"title":"Functional characterization of a clinically significant variant of IGF1R (M1054I) - a critical residue involved in defining the binding of small molecules in the allosteric pocket of IGF1R.","authors":"Farheen Showket, Aubaidah Akhtar, Sabra Parveen, Neetu Badesra, Mir Owais Ayaz, Md Mehedi Hossain, Mohmmad Saleem Dar, Razak Hussain, Pankaj Keshari, Riyaz A Mir, Mohd Jamal Dar","doi":"10.1080/08977194.2025.2606677","DOIUrl":"10.1080/08977194.2025.2606677","url":null,"abstract":"<p><p>IGF1R, a receptor tyrosine kinase, is crucial for cell growth, proliferation, and differentiation. Overexpression of IGF1R is linked to cancer and resistance to therapies, making it a target for drug development. Previously, we identified an allosteric binding pocket in IGF1R, which could be exploited for the development of IGF1R specific small molecule inhibitors. A recent study linked M1054I variant to growth defects and microcephaly. In this study, we functionally characterized M1054I to assess its effects on kinase activity, downstream signaling, and receptor structure. Replacing methionine with isoleucine at position 1054 leads to complete loss of kinase activity. Consequently, activation of downstream signaling molecules is significantly reduced in cells carrying the M1054I mutation. Structural analysis reveals that the mutation causes conformational changes in key conserved regions, particularly in the activation loop, compromising IGF1R's structural integrity and function. Additionally, the roles of residues Y987 and K1033 in regulating IGF1R functions were examined.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"42-52"},"PeriodicalIF":1.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-02-01Epub Date: 2026-02-06DOI: 10.1080/08977194.2026.2626057
Nesrine Fourti, Manel Ben Halima, Wiem Zidi, Mohamed Sami Mourali, Haifa Sanhaji, Monia Allal-Elasmi
{"title":"Extracellular matrix biomarkers and transforming growth factor-β in hypertrophic cardiomyopathy: interaction between biomarkers.","authors":"Nesrine Fourti, Manel Ben Halima, Wiem Zidi, Mohamed Sami Mourali, Haifa Sanhaji, Monia Allal-Elasmi","doi":"10.1080/08977194.2026.2626057","DOIUrl":"10.1080/08977194.2026.2626057","url":null,"abstract":"<p><p>Significant dysregulation of matrix metalloproteinase (MMPs), their tissue inhibitors (TIMPs) and profibrotic cytokines have been reported in hypertrophic cardiomyopathy (HCM) and associated with adverse cardiac remodeling. We aim to investigate the relationship among MMPs, TIMPs, transforming growth factor-β (TGF-β) and amino terminal propeptide of type III procollagen (PIIINP) in HCM patients, and to explore their associations with clinical outcomes. We recruited 46 HCM patients and 49 controls, and measured biomarkers levels using ELISA. Receiver operating characteristic (ROC) analysis revealed the highest diagnostic sensitivity for MMP-2 (93.3%) and specificity for TGF-β (90%). Significant correlations were found between biomarkers and clinical parameters, including interactions between TGF-β and left ventricular mass, MMP-2 and intraventricular septum, PIIINP and maximal wall thickness. We suggest that TGF-β, with the highest specificity and MMP-2, with high sensitivity, may offer significant potential for identifying patients with HCM and serve as useful biomarkers for this disease.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"53-63"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146124816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-02-01Epub Date: 2026-02-23DOI: 10.1080/08977194.2026.2632046
Sonali Karhana, Yasmin Sultana, Nilanjan Saha, Nidhi, Mohd Ashif Khan
{"title":"Chorioallantoic membrane assay demonstrating pro-angiogenic properties of BRAF inhibitor: a tool to treat chronic wounds.","authors":"Sonali Karhana, Yasmin Sultana, Nilanjan Saha, Nidhi, Mohd Ashif Khan","doi":"10.1080/08977194.2026.2632046","DOIUrl":"10.1080/08977194.2026.2632046","url":null,"abstract":"<p><p>The aim of the study was to evaluate the angiogenic potential and safety of Dabrafenib, a BRAF inhibitor, for wound healing applications using the chick embryo Chorioallantoic Membrane (CAM) assay. Fertilized chicken eggs were incubated, and CAM assay was performed to assess angiogenesis. The number of blood vessels was quantified using Image J software. An irritation test was conducted by applying Dabrafenib to the CAM and observing vascular changes. Additionally, the effects of dabrafenib on the secretion of Vascular Endothelial Growth Factor (VEGF-A) and Fibroblast Growth Factor 2 (FGF2) in HaCaT cell lines were investigated. Dabrafenib demonstrated a dose-dependent pro-angiogenic effect, with a EC50 of 1.196 mM. The irritation test indicated no significant irritation with Dabrafenib. There was a 4.2-fold and 5.6-fold increase from control in the VEGF-A and FGF2 groups, respectively. Dabrafenib demonstrated angiogenic potential and was nonirritating, indicating its safety for topical application.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"64-76"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147270840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Growth factorsPub Date : 2026-02-01Epub Date: 2025-12-29DOI: 10.1080/08977194.2025.2606675
Mohammed Alkandari, Meshari Alkandari, Gamal Abdel Nasser Atia, Eman Abd El-Halim, Mohamed Mohamady Ghobashy, Hany K Shalaby, Dinesh Rokaya, Tarek Foda, Khaled Hendy, Danishuddin, Md Azizul Haque
{"title":"Growth factors loaded chitosan scaffolds as bioactive biomimetic multifunctional platforms in periodontal tissue engineering: a review.","authors":"Mohammed Alkandari, Meshari Alkandari, Gamal Abdel Nasser Atia, Eman Abd El-Halim, Mohamed Mohamady Ghobashy, Hany K Shalaby, Dinesh Rokaya, Tarek Foda, Khaled Hendy, Danishuddin, Md Azizul Haque","doi":"10.1080/08977194.2025.2606675","DOIUrl":"10.1080/08977194.2025.2606675","url":null,"abstract":"<p><p>Periodontitis causes severe tissue loss, making predictable regeneration a major challenge. Growth factor-loaded chitosan scaffolds offer a promising, multifunctional approach to enhance tissue regeneration. This review explores their design, optimization, and therapeutic potential, focusing on delivery methods, release kinetics, and biocompatibility. Studies show these scaffolds improve local delivery, sustain growth factor release, and reduce cytotoxicity while offering reinforcement and encouraging cell adhesion. Optimized release kinetics ensure a favorable prognosis, reducing the necessity for recurrent administration. Growth factor-loaded chitosan scaffolds create a biomimetic environment that supports periodontal healing, representing an innovative strategy for advancing periodontal therapy. Further research on scaffold design, growth factor combinations, and long-term outcomes is essential to refine this approach for more effective, predictable regeneration.</p>","PeriodicalId":12782,"journal":{"name":"Growth factors","volume":" ","pages":"1-41"},"PeriodicalIF":1.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145855426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}